Cas:138-38-5 4-Ethylbenzenesulfonamide manufacturer & supplier

We serve Chemical Name:4-Ethylbenzenesulfonamide CAS:138-38-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Ethylbenzenesulfonamide

Chemical Name:4-Ethylbenzenesulfonamide
CAS.NO:138-38-5
Synonyms:Benzenesulfonamide, 4-ethyl-;MFCD01365828;P-Ethylbenzenesulfonamide;4-Ethylbenzenesulfonamide;4-ethyl-benzenesulfonic acid amide;4-Aethyl-benzolsulfonsaeure-amid
Molecular Formula:C8H11NO2S
Molecular Weight:185.243
HS Code:

Physical and Chemical Properties:
Melting point:111 °C
Boiling point:329.7±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.554
PSA:68.54000
Exact Mass:185.051056
LogP:1.32

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:I; II; III


Contact us for information like Benzenesulfonamide, 4-ethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Aethyl-benzolsulfonsaeure-amid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethylbenzenesulfonamide Use and application,4-Aethyl-benzolsulfonsaeure-amid technical grade,usp/ep/jp grade.


Related News: The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. 3-(3-hydroxy-13,23,33-tetraoxidan-1-enyl)-13,23,34,43,53,63-hexaoxine manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. Propanamide, 2-(acetylamino)-N-phenyl- suppliers As one analyst noted during the call, more than $1 billion in annual sales from older AZ products are now exposed to China’s volume-based procurement (VBP) initiative, a price-cutting program that targets off-patent drugs. 5a,9b-dihydro-5H-benzocyclobut(1,2-a)indene vendor & factory.